Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:57 PM
Ignite Modification Date:
2025-12-24 @ 4:57 PM
NCT ID:
NCT04132050
Eligibility Criteria:
Inclusion Criteria:
* Japanese patients
* Patients diagnosed with idiopathic thrombocytopenic purpura at least 6 months before acquisition of consent
* Patients with a platelet count averages \<30000/μL during screening period. Each platelet count should not exceed 35000/μL.
* Patients who have used and failed or who were intolerant at least 1 typical regimen for the treatment of ITP before informed consent (with or without splenectomy)
Exclusion Criteria:
* Patients with thrombocytopenia associated with other disease
* Patients with autoimmune hemolytic anemia
* Patients with poorly controlled hypertension
* Patients with a history or active coagulopathy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT04132050
Study Brief:
Protocol Section:
NCT04132050